Pfizer-BioNTech ask FDA for emergency use authorization for COVID vaccine for children 5 to 11
If authorized, this would be the first Covid-19 vaccine for younger children.
The Facts Inside Our Reporter’s Notebook
Pharmaceutical companies Pfizer and BioNTech on Thursday asked the Food and Drug Administration for emergency use authorization from for their joint COVID-19 vaccine for children 5 to 11 years old.
If the federal agency grant the authorized, the companies' vaccine would be the first such for that age group. Their vaccine is approved for those 16 and older, and they have EUA approval for people ages 12 to 15, according to CNN.
News, not Noise
- In new book Huma Abedin claims U.S. Senator sexually assaulted her
- Leaving Atlanta: Amid rising urban crime and taxes, a secession movement grows in a moderate suburb
- Chicago set to pass one of US's biggest guaranteed income plans, amid calls to put money to violence
- Extreme couponing Virginia couple receive a combined nearly 20 years in prison for $31 million fraud
- 'Let's Go Brandon' gains widespread recognition across US, approval as form of protest, poll